Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 6139 | 1460 | 40.2 | 90% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 124 | 23152 | HEPATITIS B VIRUS//CHRONIC HEPATITIS B//HEPATITIS B |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | PATHOGENESE VIRUS HEPATITE B | Address | 27 | 83% | 1% | 15 |
| 2 | WOODCHUCK HEPATITIS VIRUS | Author keyword | 7 | 32% | 1% | 19 |
| 3 | WOODCHUCK | Author keyword | 7 | 28% | 2% | 22 |
| 4 | BIOL THER Y | Address | 6 | 21% | 2% | 25 |
| 5 | UNIT INFECT DIS HEPATOL | Address | 6 | 35% | 1% | 13 |
| 6 | HBCAG | Author keyword | 6 | 24% | 1% | 20 |
| 7 | INFECT IMMUN PROGRAM | Address | 5 | 63% | 0% | 5 |
| 8 | PROGRAM EMERGING VIRAL DIS | Address | 5 | 50% | 0% | 7 |
| 9 | VIRAL IMMUNOPATHOL | Address | 4 | 39% | 1% | 9 |
| 10 | BEIJING INFECT DIS | Address | 4 | 31% | 1% | 12 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | WOODCHUCK HEPATITIS VIRUS | 7 | 32% | 1% | 19 | Search WOODCHUCK+HEPATITIS+VIRUS | Search WOODCHUCK+HEPATITIS+VIRUS |
| 2 | WOODCHUCK | 7 | 28% | 2% | 22 | Search WOODCHUCK | Search WOODCHUCK |
| 3 | HBCAG | 6 | 24% | 1% | 20 | Search HBCAG | Search HBCAG |
| 4 | MARMOTA HIMALAYANA | 4 | 67% | 0% | 4 | Search MARMOTA+HIMALAYANA | Search MARMOTA+HIMALAYANA |
| 5 | INTRAHEPATIC IMMUNE RESPONSE | 4 | 75% | 0% | 3 | Search INTRAHEPATIC+IMMUNE+RESPONSE | Search INTRAHEPATIC+IMMUNE+RESPONSE |
| 6 | WOODCHUCK MODEL | 4 | 75% | 0% | 3 | Search WOODCHUCK+MODEL | Search WOODCHUCK+MODEL |
| 7 | CHRONIC HEPATITIS B VIRUS INFECTION | 4 | 23% | 1% | 14 | Search CHRONIC+HEPATITIS+B+VIRUS+INFECTION | Search CHRONIC+HEPATITIS+B+VIRUS+INFECTION |
| 8 | CYTOPLASMIC TRANSDUCTION PEPTIDE | 3 | 57% | 0% | 4 | Search CYTOPLASMIC+TRANSDUCTION+PEPTIDE | Search CYTOPLASMIC+TRANSDUCTION+PEPTIDE |
| 9 | CHRONIC HBV INFECTION | 3 | 23% | 1% | 13 | Search CHRONIC+HBV+INFECTION | Search CHRONIC+HBV+INFECTION |
| 10 | WHV | 3 | 43% | 0% | 6 | Search WHV | Search WHV |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NUCLEOCAPSID ANTIGEN | 31 | 43% | 4% | 54 |
| 2 | INTRACELLULAR INACTIVATION | 28 | 56% | 2% | 35 |
| 3 | NONPARENCHYMAL LIVER CELLS | 26 | 55% | 2% | 32 |
| 4 | VIRUS NUCLEOCAPSID ANTIGEN | 17 | 62% | 1% | 18 |
| 5 | HBV INFECTION | 17 | 16% | 7% | 99 |
| 6 | VACCINE THERAPY | 12 | 48% | 1% | 19 |
| 7 | CHRONIC HBV INFECTION | 11 | 20% | 3% | 49 |
| 8 | HLA DPA1 | 11 | 100% | 0% | 6 |
| 9 | WHV CORE ANTIGEN | 11 | 69% | 1% | 9 |
| 10 | ACUTE VIRAL HEPATITIS | 10 | 15% | 4% | 61 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| HBV and the immune response | 2015 | 6 | 76 | 74% |
| Innate immune responses in hepatitis B virus (HBV) infection | 2014 | 15 | 55 | 62% |
| The immune tolerant phase of chronic HBV infection: new perspectives on an old concept | 2015 | 4 | 45 | 47% |
| Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection | 2015 | 2 | 72 | 64% |
| The immune response during hepatitis B virus infection | 2006 | 173 | 107 | 61% |
| Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges | 2011 | 46 | 79 | 71% |
| Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses | 2015 | 2 | 90 | 51% |
| Immunology of hepatitis B virus and hepatitis C virus infection | 2005 | 806 | 124 | 23% |
| Dissecting the dendritic cell controversy in chronic hepatitis B virus infection | 2015 | 1 | 54 | 70% |
| Therapeutic vaccines in treating chronic hepatitis B: the end of the beginning or the beginning of the end? | 2015 | 1 | 57 | 68% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PATHOGENESE VIRUS HEPATITE B | 27 | 83% | 1.0% | 15 |
| 2 | BIOL THER Y | 6 | 21% | 1.7% | 25 |
| 3 | UNIT INFECT DIS HEPATOL | 6 | 35% | 0.9% | 13 |
| 4 | INFECT IMMUN PROGRAM | 5 | 63% | 0.3% | 5 |
| 5 | PROGRAM EMERGING VIRAL DIS | 5 | 50% | 0.5% | 7 |
| 6 | VIRAL IMMUNOPATHOL | 4 | 39% | 0.6% | 9 |
| 7 | BEIJING INFECT DIS | 4 | 31% | 0.8% | 12 |
| 8 | UNITE CARCINOGENESE HEPAT VIROL MOL | 4 | 75% | 0.2% | 3 |
| 9 | SING ORE CLIN SCI | 4 | 12% | 2.0% | 29 |
| 10 | MED MICROBIOL BIOMED SCI | 3 | 57% | 0.3% | 4 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000155966 | INTEGRATED PROGRAM IMMUNOL//DENDRIT CELL BIOL CLIN PLICAT//LIVER DIS SECT |
| 2 | 0.0000150359 | INTERNAL MED MOL BIOL 2//HEPADNAVIRUS//DUCK HEPATITIS B VIRUS |
| 3 | 0.0000121756 | CHRONIC HEPATITIS B//ENTECAVIR//LAMIVUDINE |
| 4 | 0.0000106414 | HEPATITIS B VIRUS//PRECORE//PRECORE MUTATION |
| 5 | 0.0000075410 | HBV REACTIVATION//HEPATITIS B VIRUS REACTIVATION//HEPATITIS B REACTIVATION |
| 6 | 0.0000066529 | HBX//HEPATITIS B VIRUS X PROTEIN//X PROTEIN |
| 7 | 0.0000062571 | IGM ANTI HBC//ANTI HBC IGM//HBVDNA |
| 8 | 0.0000060725 | TNFAIP8//TIPE2//TNFAIP8L2 TIPE2 |
| 9 | 0.0000059920 | IFN LAMBDA//IL 29//INTERLEUKIN 29 |
| 10 | 0.0000058772 | BIO NANOCAPSULE//RECOMBINANT HEPATITIS B SURFACE ANTIGEN//PRE S1 |